Next Article in Journal
Dissolvable Microneedle Patches to Enable Increased Access to Vaccines against SARS-CoV-2 and Future Pandemic Outbreaks
Next Article in Special Issue
COVID-19 Vaccine Hesitancy among Young Adults in Saudi Arabia: A Cross-Sectional Web-Based Study
Previous Article in Journal
Willingness to Pay for a Hypothetical COVID-19 Vaccine in the United States: A Contingent Valuation Approach
Previous Article in Special Issue
Measurement Invariance of the Drivers of COVID-19 Vaccination Acceptance Scale: Comparison between Taiwanese and Mainland Chinese-Speaking Populations
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Vaccines
Volume 9
Issue 4
10.3390/vaccines9040319
Review Report
vaccines-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Review
Peer-Review Record

Demand Creation for COVID-19 Vaccination: Overcoming Vaccine Hesitancy through Social Marketing

Vaccines 2021, 9(4), 319; https://doi.org/10.3390/vaccines9040319
by William Douglas Evans 1,* and Jeff French 2
Reviewer 1:
Brian Crook
Reviewer 2: Anonymous
Vaccines 2021, 9(4), 319; https://doi.org/10.3390/vaccines9040319
Submission received: 7 March 2021 / Revised: 22 March 2021 / Accepted: 23 March 2021 / Published: 1 April 2021
(This article belongs to the Special Issue Vaccination and Public Health Version II: COVID-19 Vaccination)

Round 1

Reviewer 1 Report

This is a highly relevant and pertinent discussion piece about vaccine hesitancy which is a major problem at the moment.  Other than minor editorial corrections, the main suggestion I would make, in order to make the paper right up to date, is to add a paragraph about the latest situation in Europe with vaccine hesitancy. This should be referenced from media, but in summary a few weeks ago France stopped using the AZ vaccine because there was no evidence from clinical trials (because they weren't included) of efficacy against over 65s which was misinterpreted as the vaccine is not effective against over 65s, which led to them stopping use. Then more recently concern over possible side effects led to cessation of use until the European medicines regulator declared it safe, but the damage to the vaccine programme in Europe is significant in terms of public confidence.

 

  

Author Response

Thank you. We have made minor editorial corrections and have added a paragraph about the situation in Europe noted by the reviewer.

Reviewer 2 Report

I was invited to revise the paper entitled "Demand creation for COVID-19 vaccination: Overcoming vaccine hesitancy through social marketing". This review aimed to summarize possible strategies against covid19 vaccine hesitancy, highlightening factors that can influence the vaccine uptake.

The topic is very interesting and this paper is relevant, improving the knowledge in this field. 

Introduction is well presented and clearly describe the study background. In particular, the description of the importance of public figures in vaccine promotion is relevant and well focused.

Methods are adequate and well described the model proposed by Authors. In addition, figures are clear and facilitate the reading.

Discussion deeply describe the study results and are easy to read.

I only suggest to discuss about vaccine hesitancy among healthcare workers. It can be a factor that strongly influence the vaccine uptake both among HCW and public patients. 

Author Response

Thank you. We added a brief discussion of the need to promote vaccine uptake among HCW as part of a strategic approach to overcoming hesitancy. HCW are critical to building trust in the vaccine and serve as role models for patients.

Back to TopTop